ProfileGDS5822 / ILMN_1253943
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 29% 1% 45% 23% 10% 12% 0% 32% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 115.129
GSM1276600PDAC Late Ablation Control 25.31
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 117.845
GSM1276603PDAC Late Ablation 21323
GSM1276604PDAC Late Ablation 38.110
GSM1303940PDAC Late Ablation_anti-CTLA4 110.112
GSM1303941PDAC Late Ablation_anti-CTLA4 20.60
GSM1303942PDAC Late Ablation_anti-CTLA4 315.432